The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Aug. 29, 2019
Applicant:
Xenon Pharmaceuticals Inc., Burnaby, CA;
Inventors:
Jean-Christophe Andrez, Vancouver, CA;
Kristen Nicole Burford, Burnaby, CA;
Christoph Martin Dehnhardt, Burnaby, CA;
Thilo Focken, Burnaby, CA;
Michael Edward Grimwood, North Vancouver, CA;
Qi Jia, Burnaby, CA;
Verner Alexander Lofstrand, Burnaby, CA;
Steven Sigmund Wesolowski, Natick, MA (US);
Michael Scott Wilson, Burnaby, CA;
Assignee:
Xenon Pharmaceuticals Inc., Burnaby, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/14 (2006.01); A61P 25/08 (2006.01); C07C 53/18 (2006.01); C07D 401/14 (2006.01); C07D 409/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61P 25/08 (2018.01); C07C 53/18 (2013.01); C07D 401/14 (2013.01); C07D 409/14 (2013.01);
Abstract
This invention is directed to heteroaryl-substituted sulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.